Project Details
Description
A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients with Pyoderma Gangrensoum
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/15 → 12/31/18 |
Funding
- XOMA CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.